Holliston life science tools company Harvard Bioscience Inc. saw its Q1 revenues drop 13.2 percent to $19.1 million while net income rose from $687,000 to $1.8 million.
The company said its performance was in line with its expectations despite the recession and concerns about foreign exchange rates. It reconfirmed projections of $80 to $85 million in revenue for the year.
Harvard Bioscience said it hopes to double revenues and profits over the next three to five years through operational efficiencies, new product development and acquisitions.
